The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.

Source:http://linkedlifedata.com/resource/pubmed/id/17083268

Download in:

View as

General Info

PMID
17083268